Prof. Dr. Rupam Borgohain

Dr.Rupam is a Senior Consultant Neurologist and Programme Director-PDMDRC
(Parkinson’s Disease and Movement Disorders Research Centre)

Educational Qualifications:
  • 1991: D.M. Neurology, NIMHANS, Bangalore, India
  • 1985: Internship,Safdarjung Hospital, New Delhi, India.
  • 1983: MBBS, Assam Medical College, Dibrugarh,India.
Experience:
  • 2000 to 2005: Additional Professor of Neurology,NIMS, Hyderabad.
  • 1996 to 2000: Associate Professor of Neurology, NIMS, Hyderabad.
  • 1992 to 1996: Assistant Professor of Neurology, Nizam's Institute of Medical Sciences, Hyderabad
  • 1992: Assistant Professor in Neurology, MS Ramaiah Medical College, Bangalore.
  • 1989 to 1992: Senior Resident in Neurology,NIMHANS, Bangalore.
  • 1985 to 1989: Junior Resident in Neurology: NIMHANS, Bangalore.
Services Offered:
  • Treatment for all Movement Disorders
  • Deep Brain Stimulation (DBS)
  • Botulinum Toxin Injection (Botox Therapy)
Special Interest and Expertise:
  • Movement Disorder Specialist
  • Expertise in Deep Brain Stimulation (DBS)
  • Botulinum toxin Injection for various disease like Writers cramp, Dystonia (Cervical, Oromandibular, dysphonia), Hemi facial spasm, spasticity, migraine, trigeminal Neurolgia:
Professional Membership:
  • Member – Movement Disorder Society
  • Life Member – Indian Academy of Neurology
  • Life Member – Neurological Society of India
  • Life Member – AP Neurological Society
  • Member – Twin Cities Neurological Society
Research & Publications:
  • Metta V, Chaudhuri KR, Leta V, Mridula KR, Koduri C, Deepak S, Kalpala R, Reddy N, Chung-Faye G, Borgohain R. Real-life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1-year follow-up data report. Brain Behav. 2022 Sep;12(9):e2547. doi: 10.1002/brb3.2547.
  • Kukkle PL, Geetha TS, Chaudhary R, Sathirapongsasuti JF, Goyal V, Kandadai RM, Kumar H, Borgohain R, Mukherjee A, Oliver M, Sunil M, Mootor MFE, Kapil S, Mandloi N, Wadia PM, Yadav R, Desai S, Kumar N, Biswas A, Pal PK, Muthane UB, Das SK, Sakthivel Murugan SM, Peterson AS, Stawiski EW, Seshagiri S, Gupta R, Ramprasad VL, Prai PRAOI. Genome-Wide Polygenic Score Predicts Large Number of High Risk Individuals in Monogenic Undiagnosed Young Onset Parkinson's Disease Patients from India. Adv Biol (Weinh). 2022 Nov;6(11):e2101326. doi: 10.1002/adbi.202101326.
  • Meka SSL, Kandadai RM, Alugolu R, Haragopal VV, Borgohain R. Effect of Medication and Deep Brain Stimulation on Gait in Parkinson's Disease and its Quantitative Analysis Using Mobishoe - A Comparative Study. Ann Indian Acad Neurol. 2023 Mar-Apr;26(2):156-160. doi: 10.4103/aian.aian_769_22.
  • Andrews SV, Kukkle PL, Menon R, Geetha TS, Goyal V, Kandadai RM, Kumar H, Borgohain R, Mukherjee A, Wadia PM, Yadav R, Desai S, Kumar N, Joshi D, Murugan S, Biswas A, Pal PK, Oliver M, Nair S, Kayalvizhi A, Samson PL, Deshmukh M, Bassi A, Sandeep C, Mandloi N, Davis OB, Roberts MA, Leto DE, Henry AG, Di Paolo G, Muthane U, Das SK, Peterson AS, Sandmann T, Gupta R, Ramprasad VL; Parkinson Research Alliance of India (PRAI). The Genetic Drivers of Juvenile, Young, and Early-Onset Parkinson's Disease in India. Mov Disord. 2024 Feb;39(2):339-349. doi: 10.1002/mds.29676.
  • Mathukumalli NL, Kandadai MR, Shaik JA, Kanikannan MA, Borgohain R. Serum B12, Homocysteine Levels, and their Effect on Peripheral Neuropathy in Parkinson's Disease: Indian Cohort. Ann Indian Acad Neurol. 2020 Jan-Feb;23(1):48-53. doi: 10.4103/aian.AIAN_478_18.
  • Kolpakwar S, Arora AJ, Pavan S, Kandadai RM, Alugolu R, Saradhi MV, Borgohain R. Volumetric analysis of subthalamic nucleus and red nucleus in patients of advanced Parkinson's disease using SWI sequences. Surg Neurol Int. 2021 Jul 27;12:377. doi: 10.25259/SNI_584_2021.
  • Sireesha Y, Kanikannan MA, Pyal A, Sandeep G, Uppin MS, Kandadai RM, Jabeen SA, Varaprasad R, Rajasekhar L, Neeharika ML, Borgohain R. Patterns of peripheral neuropathy in Sjogren's syndrome in a tertiary care hospital from South India. Neurol India. 2019 Jan-Feb;67(Supplement):S94-S99. doi: 10.4103/0028-3886.250714.
  • Srivastava MK, Shaik AJ, Yareeda S, Nallapareddy K, Lingappa L, Moturi P, Gaddamonugu P, Kandadai RM, Borgohain R. Neurocognitive Profile and F-Fluorodeoxyglucose Positron Emission Tomography Brain Imaging Correlation in Children with Electrical Status Epilepticus during Sleep. World J Nucl Med. 2023 Jun 27;22(3):174-182. doi: 10.1055/s-0042-1757284.
  • Tandra S, Ramavath B, Kandadai RM, Jabeen SA, Kannan MA, Borgohain R. Functional Outcome of Bilateral Subthalamic Nucleus-Deep Brain Stimulation in Advanced Parkinson's Disease Patients: A Prospective Study. Ann Indian Acad Neurol. 2020 Jan-Feb;23(1):54-58. doi: 10.4103/aian.AIAN_357_18.
  • Metta V, Ibrahim H, Muralidharan N, Rodriguez K, Masagnay T, Mohan J, Lacsina A, Ahmed A, Benamer HTS, Chung-Faye G, Mrudula R, Falup-Pecurariu C, Rodriguez-Blazquez C, Borgohain R, Goyal V, Bhattacharya K, Chaudhuri KR. A 12-month prospective real-life study of opicapone efficacy and tolerability in Emirati and non-White subjects with Parkinson's disease based in United Arab Emirates. J Neural Transm (Vienna). 2024 Jan;131(1):25-30. doi: 10.1007/s00702-023-02700-y.
  • Tandra S, Kandadai RM, Peddisetty RP, Babu KJ, Prabha TS, Jabeen SA, Meena AK, Borgohain R. The Effect of Dual Tasking and Deep Brain Stimulation Frequency Parameters on Gait in Advanced Parkinson's Disease. Ann Indian Acad Neurol. 2020 May-Jun;23(3):308-312. doi: 10.4103/aian.AIAN_11_19.